Twitter | Search | |
U.S. FDA
Here you'll find the latest US Food and Drug Administration news and information. Privacy Policy -
10,521
Tweets
150
Following
212,206
Followers
Tweets
U.S. FDA retweeted
Scott Gottlieb, M.D. 15h
FDA is protecting patients from exposure to drugs that may be counterfeit, stolen, contaminated or otherwise harmful. The three guidances issued today will help industry enhance the security of the supply chain:
Reply Retweet Like
U.S. FDA retweeted
Scott Gottlieb, M.D. 19h
THREAD: (1/2) issued final guidance today on labeling of devices and combination products containing heparin following serious adverse events in patients. It clarifies new expectations for labeling, outlines safety testing to improve safety.
Reply Retweet Like
U.S. FDA retweeted
FDA FOOD 19h
FDA has resources for food producers in flooded areas! FDA has information that can be used for assessing potential damage to your food crops plus contact info.
Reply Retweet Like
U.S. FDA retweeted
Media Affairs 21h
Statement from FDA Commissioner on the FDA’s ongoing efforts to prevent foodborne outbreaks of Cyclospora
Reply Retweet Like
U.S. FDA retweeted
Scott Gottlieb, M.D. 20h
As people return home and businesses begin to reopen, is committed to providing safety tips for the general public and technical assistance for businesses, such as advice on Restaurants and Grocers Reopening After Hurricanes and Flooding:
Reply Retweet Like
U.S. FDA 21h
ICYMI: FDA unveiled a new e-cigarette prevention campaign aimed at educating youth about the potential dangers caused by e-cigarette use. ⚡️
Reply Retweet Like
U.S. FDA retweeted
USDA Food Safety Sep 15
Flood waters can carry harmful diseases and bacteria. Before salvaging canned food from water, make sure it’s safe! Screw-caps, snap lids, pull tops & crimped tops are NOT waterproof. More tips ↓
Reply Retweet Like
U.S. FDA retweeted
Scott Gottlieb, M.D. Sep 18
Unfortunately, flooding from has not ended in many places in the Carolinas. The will continue to closely monitor flooding for any potential impacts to FDA-regulated facilities and continue to provide technical assistance to state and local partners.
Reply Retweet Like
U.S. FDA Sep 18
Big thanks to for having us today! And thanks to , , , Director Nora Volkow, , , , and all who participated for the great chat on pain management and the opioid crisis. !
Reply Retweet Like
U.S. FDA retweeted
NLM SIS Sep 18
A10: Read the latest reports, guidelines, etc., on pain and the opioid crisis in Disaster Lit:
Reply Retweet Like
U.S. FDA Sep 18
A10: Learn about FDA’s work to address the opioid crisis, which aims to prevent abuse while providing patients in pain access to treatment.
Reply Retweet Like
U.S. FDA retweeted
NIDAnews Sep 18
A9: We must address not only the stigma against people with opioid use disorder, but also the stigma among treatment providers against the use of agonist medications to treat .
Reply Retweet Like
U.S. FDA Sep 18
A9: There’s an urgent need to ensure access to, and wider use and understanding of, MAT for opioid use disorder. Learn more about MAT and steps ’s taking to encourage more widespread innovation/development of MAT:
Reply Retweet Like
U.S. FDA Sep 18
A9: Our efforts with will be to help the public, patients, healthcare professionals learn more about the availability and proper use of MAT and break the stigma that keeps many Americans who are seeking a life of sobriety from reaching their goal.
Reply Retweet Like
U.S. FDA Sep 18
A9: FDA remains committed to addressing the opioid crisis on all fronts, w/ a significant focus on several key areas, incl. supporting treatment of those with opioid use disorder. Learn more about our efforts to encourage new treatments & :
Reply Retweet Like
U.S. FDA retweeted
SAMHSA Sep 18
A7. See how is working with partners around the country to empower communities and address the public health emergency:
Reply Retweet Like
U.S. FDA Sep 18
Replying to @US_FDA
A8: We’re optimistic this work will result in new, data-driven guidelines from medical professional societies that can be easily accessible to prescribers to decrease unnecessary/inappropriate exposure to opioids while ensuring appropriate treatment for patients w/ medical need.
Reply Retweet Like
U.S. FDA Sep 18
A8: FDA is taking new steps to advance the development of evidence-based, indication-specific guidelines to help guide appropriate prescribing of opioid analgesics:
Reply Retweet Like
U.S. FDA Sep 18
A8: FDA supports and efforts to encourage informed opioid prescribing.
Reply Retweet Like
U.S. FDA Sep 18
A7: FDA supports development of new and innovative treatment options for opioid dependence. Additionally, we require companies to provide education for prescribers on appropriate use of Rx opioids.
Reply Retweet Like